The Molecular Genetics Program conducts fundamental research on the etiology, progression, prevention, detection, and treatment of cancer. The scientific foci of the group are on DNA damage, DNA repair, gene regulation, hormonal responsiveness, viral carcinogenesis, and familial cancer gene identification.. The 31 member5 group has weekly data presentation meetings, mini-symposia, and annual poster sessions in addition to the weekly Cancer Center Grand Rounds, as forums for interaction. The Molecular Genetics Program is sub-divided into four focus groups: Genetic Instability, Gene Control, Molecular Virology, and Human Cancer Center Grand Rounds, as forums for interaction. The Molecular Virology and Human Cancer Genetics. Several major cancer research discoveries have been made in the previous funding interval in this Program. Important new strides have been made in defining how DNA damage is repaired. Insights from this are important in understanding how chromosomal instability permits cancers to diversity as part of their progression. The Molecular Genetics Program members have discovered cancers to diversity as part of their progression. The Molecular Genetics Program members have discovered new proteins (and their genes) that are critical to how nuclear hormone receptors function, and this is relevant to the hormonal dependence on breast and prostate cancer. Major progress has also been made in defining a novel pathway for altering gene expression by acetylation of transcription factors. Marked progress has been made in understanding the molecular basis for the persistence of hepatitis C virus, which is important to its causing hepatocellular carcinoma. Other program members are collaborating to examine breast and prostate cancers for mutations in the newly described nuclear hormone receptor mentioned above. Genetic linkage analysis of prostate cancer families is underway, and is integrated into an international consortium. The analysis of prostate cancer families is underway, and is integrated into an international consortium. The Molecular Genetics Program members have been successful in developing or participating in program project grants in gene therapy and DNA repair as a result of the fruitful scientific interaction fostered by this Program. Hence, both scientific collaborations and cancer research discoveries are facilitated by the existence of the Molecular Genetics Program.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA014089-26
Application #
6457494
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
1980-04-01
Project End
2005-11-30
Budget Start
Budget End
Support Year
26
Fiscal Year
2001
Total Cost
Indirect Cost
Name
University of Southern California
Department
Type
DUNS #
041544081
City
Los Angeles
State
CA
Country
United States
Zip Code
90033
Lang, Julie E; Brownson, Kirstyn E (2018) ASO Author Reflections: The Whole Transcriptome Landscape of Circulating Tumor Cells in Nonmetastatic Breast Cancer. Ann Surg Oncol :
Poulard, Coralie; Baulu, Estelle; Lee, Brian H et al. (2018) Increasing G9a automethylation sensitizes B acute lymphoblastic leukemia cells to glucocorticoid-induced death. Cell Death Dis 9:1038
Guo, Yu; Perez, Andrew A; Hazelett, Dennis J et al. (2018) CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops. Genome Biol 19:160
Milam, Joel; Slaughter, Rhona; Tobin, Jessica L et al. (2018) Childhood Cancer Survivorship and Substance Use Behaviors: A Matched Case-Control Study Among Hispanic Adolescents and Young Adults. J Adolesc Health 63:115-117
Singh, Hardeep P; Wang, Sijia; Stachelek, Kevin et al. (2018) Developmental stage-specific proliferation and retinoblastoma genesis in RB-deficient human but not mouse cone precursors. Proc Natl Acad Sci U S A 115:E9391-E9400
Suenaga, Mitsukuni; Schirripa, Marta; Cao, Shu et al. (2018) Potential role of PIN1 genotypes in predicting benefit from oxaliplatin-based and irinotecan-based treatment in patients with metastatic colorectal cancer. Pharmacogenomics J 18:623-632
Tsai, Yuan-Li; Ha, Dat P; Zhao, He et al. (2018) Endoplasmic reticulum stress activates SRC, relocating chaperones to the cell surface where GRP78/CD109 blocks TGF-? signaling. Proc Natl Acad Sci U S A 115:E4245-E4254
Rodrigues, Luana L S; Morgado, Mariza G; Sahasrabuddhe, Vikrant V et al. (2018) Cervico-vaginal self-collection in HIV-infected and uninfected women from Tapajós region, Amazon, Brazil: High acceptability, hrHPV diversity and risk factors. Gynecol Oncol 151:102-110
Valentin-Torres, Alice; Savarin, Carine; Barnett, Joslyn et al. (2018) Blockade of sustained tumor necrosis factor in a transgenic model of progressive autoimmune encephalomyelitis limits oligodendrocyte apoptosis and promotes oligodendrocyte maturation. J Neuroinflammation 15:121
Ricker, Charité N; Koff, Rachel B; Qu, Chenxu et al. (2018) Patient communication of cancer genetic test results in a diverse population. Transl Behav Med 8:85-94

Showing the most recent 10 out of 842 publications